Recon: Sanofi inks $1.7B deal with Dren Bio for autoimmune therapy; MHRA approves GSK’s twice-yearly asthma treatment
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States